Skip to main content

MJFF Publications

4951 - 4960 of 7665 Results
Title
Year
  • Year
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • 2019
  • RESTRICTED
    Title: Manganese promotes the aggregation and prion-like cell-to-cell exosomal transmission of α-synuclein
    Journal Name: Science Signaling
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scisignal.aau4543
    Citation Count: 124
  • RESTRICTED
    Title: Vitamin B12 modulates Parkinson’s disease LRRK2 kinase activity through allosteric regulation and confers neuroprotection
    Journal Name: Cell Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1038/s41422-019-0153-8
    Citation Count: 44
  • RESTRICTED
    Title: Artificial Neural Network–Based Prediction of Outcome in Parkinson’s Disease Patients Using DaTscan SPECT Imaging Features
    Journal Name: Molecular Imaging and Biology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s11307-019-01334-5
    Best OA location URL:
    Citation Count: 30
  • RESTRICTED
    Title: Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson’s disease pathogenesis
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-019-08858-y
    Citation Count: 224
  • RESTRICTED
    Title: Comparative study of cerebrospinal fluid α‐synuclein seeding aggregation assays for diagnosis of Parkinson's disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.27646
    Citation Count: 151
  • RESTRICTED
    Title: Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: Proceedings of the National Academy of Sciences
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.1814909116
    Citation Count: 83
  • RESTRICTED
    Title: Reduced habit-driven errors in Parkinson’s Disease
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-019-39294-z
    Citation Count: 9
  • RESTRICTED
    Title: Higher urate in LRRK2 mutation carriers resistant to Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25436
    Best OA location URL:
    Citation Count: 44
  • RESTRICTED
    Title: A comprehensive screening of copy number variability in dementia with Lewy bodies
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2018.10.019
    Citation Count: 14
  • RESTRICTED
    Title: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience Data
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088
    Best OA location URL:
    Citation Count: 0
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.